Clinical Trials

Discover how advancements in unified systems, patient diversity, and regulatory submissions will accelerate drug development & improve patient outcomes.

Discover how AI is transforming personalised medicine and patient-specific treatments and how data integration can revolutionise drug discovery and healthcare.

Discover how AI and protein pattern analysis are transforming disease prediction. Latest research from Optima Partners, Biogen, and the University of Edinburgh.

Discover how Otsuka and Oxford HIN are collaborating to evaluate and implement CARE for MDD, a digital therapeutic designed to treat major depressive disorder.

Discover how AI and patient-on-chip technology are revolutionising drug discovery and development.

Discover how Artificial Intelligence (AI) is revolutionizing pharmaceutical research and development in this insightful article featuring Renee Iacona, Vice President of Oncology Biometrics at AstraZe...

Explore how AI/ML can accelerate rare disease research and clinical trials, by enhancing inclusivity and efficiency, to deliver new drugs and therapeutics to patients. With insights from Dr. Harsha Ra...

Yusuf Henriques, founder of IndyGeneUS AI, tells Pharma IQ about the need to rethink precision medicine

As Bayer tops list for DEI efforts, we look at how this impacts clinical research

Pharma IQ takes a look at the benefits and challenges of decentralized clinical trials in clinical research

CRISPR therapy shows promise as a cure for severe sickle cell disease

Pharma IQ speaks to AstraZeneca about its promising new drug candidate to tackle one of the world’s leading causes of death